Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Endocrine Research|May 18, 2012
Tissue-selective regulation of androgen-responsive genesMaya Otto-Duessel, Miaoling He, Jeremy O JonesJournal of Molecular Endocrinology|May 28, 2013
Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissueYe Zhou, Maya Otto-Duessel, Miaoling He, et al.Journal of Cancer Research and Therapeutic Oncology|December 20, 2021
Androgen Receptor and PI3K Pathway Activity in Ovarian CancerAddie Hill, Mihaela Cristea, Miaoling He, et al.The Prostate|December 16, 2016
Low Testosterone Alters the Activity of Mouse Prostate Stem CellsYe Zhou, Ben Copeland, Maya Otto-Duessel, et al.ACS Chemical Biology|December 21, 2013
Ligand-independent and tissue-selective androgen receptor inhibition by pyrviniumMinyoung Lim, Maya Otto-Duessel, Miaoling He, et al.Urologic Oncology|January 1, 2018
Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamideSumanta K Pal, Miaoling He, Lin Chen, et al.ACS Omega|March 16, 2019
Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor PyrviniumSumanta K Pal, Ben Yi Tew, Minyoung Lim, et al.Analytical Chemistry|April 18, 2019
Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent NanoprobeYunshi Fan, Mi Lu, Xie-An Yu, et al.Urologic Oncology|November 28, 2016
Vitamin K epoxide reductase expression and prostate cancer riskBen Yi Tew, Sumanta K Pal, Miaoling He, et al.Cancer|December 22, 2017
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)Sumanta Kumar Pal, Jaymala Patel, Miaoling He, et al.Pageof 2